01269nas a2200289   4500000000100000008004100001260001300042653003000055653001100085653002200096653001100118653001400129653002300143653001200166653000900178653002500187653001500212653002600227653001700253653002200270100001800292245004800310300001000358490000700368520059000375022001400965       1996                            d  c1996 Oct10aDrug Therapy, Combination10aFemale10aFollow-Up Studies10aHumans10aIncidence10aLeprostatic Agents10aleprosy10aMale10aMycobacterium leprae10aRecurrence10aRetrospective Studies10aRisk Factors10aTreatment Outcome1 aDasananjali K00aRelapse of leprosy after multidrug therapy.  a635-90 v793 a<p>Relapse of leprosy after multidrug therapy among leprosy patients treated at Mahasarakarm, Kalasin and Roi-et from 1984 to 1994 were analyzed. Twenty PB relapses (45.45%) and twenty four MB relapses (54.55%) were found among 5,298 originally classified PB patients and 5 MB relapses occurred in 2,624 originally classified MB patients. Mean relapse interval was between 3-4 years. The relapse rate within 10 years after stopping MDT was 0.83 per cent in PB and 0.19 per cent in MB. The estimated relapse rate per 1,000 patient-years was 1.55 for PB and 0.41 for MB respectively.</p>  a0125-2208